The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung ...

Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients with previously ...

Patients with resectable stage II–IIIB non-small cell lung cancer (NSCLC) treated with perioperative atezolizumab plus ...

Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), ...

Adding local consolidative therapy (LCT) after induction treatment with nivolumab plus ipilimumab did not improve overall ...

New research to be presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, ...

A new study, published Sept. 11, 2026, in The American Journal of Human Genetics provides one possible answer: some genetic ...

A multidisciplinary scientific team at the University of Malaga has developed a new technology based on magnetic ...

Neurons receive thousands of signals via tree-like extensions called dendrites. Until now, these dendrites were thought to be ...

According to a Finnish study, people sleep slightly longer when they work from home. However, they also sit more and are less ...

People with autism often come at life from a different angle-seeing details others miss, focusing on patterns rather than ...

Custom search configurations optimize automated synthesis routes for higher success rates, faster planning, and more.